Actively Recruiting
Study on Early Identification Program to Reduce Untreated Psychosis Duration in First-Episode Psychosis Patients Aged 15 to 35
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-11-24
416
Participants Needed
6
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the impact of an early identification program called PRESTO on the duration of untreated psychosis DUP in people experiencing First-Episode Psychosis FPE. FPE is a serious condition that can include delusions, cognitive problems, and suicidal behavior. Since more than 80% of FPE cases can develop into schizophrenia, reducing the time before starting adequate psychiatric care may improve short- and long-term outcomes. This study aims to show how facilitating access to specialized care through PRESTO affects this critical time period. The PRESTO program includes three main parts raising awareness about psychotic disorders among the general population, training front-line actors such as general practitioners and emergency responders about FPE and its management, and improving access to specialized psychiatric care by using mobile teams that link front-line actors and specialized services. Participants are assigned either to receive the PRESTO program or to continue with usual care without changes in referral conditions. Participants will be involved in assessments including measurement of the duration of untreated psychosis at baseline. Follow-up evaluations at week 4 will assess ongoing care engagement, treatment adherence, therapeutic alliance, customer satisfaction, and caregiver burden. The study will also analyze the context before and after the PRESTO program implementation. The total participation duration varies, with ongoing monitoring of care and outcomes planned. This study is sponsored by Centre Hospitalier Universitaire de Saint Etienne and is randomized without masking.
CONDITIONS
Brief Title
Impact of an Early Identification Program for First-Episode Psychosis on the Duration of Untreated Psychosis
Research Team
E
Eric FAKRA, MD PhD
A
Amandine BAUDOT, CRA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here